Diagnostic value of cerebrospinal fluid level of carcinoembryonic antigen in patients with leptomeningeal carcinomatous metastasis

Journal of Clinical Neurology (Korea)

Volumn 6, Issue 1, 2010, Pages 33-37

  Kang, Sung Jin ^a   Kim, Kwang Soo ^a   Ha, Yoon Suk ^a   Huh, So Young ^a   Lee, Ji Hyun ^a   Kim, Jong Kuk ^a   Kim, Min Jeong ^a  

^a Kosin University   (South Korea)

Author keywords

Carcinoembryonic antigen; Cerebrospinal fluid; Leptomeningeal metastasis

Indexed keywords

EID: 78651519665     PISSN: 17386586     EISSN: 20055013     Source Type: Journal    
DOI: 10.3988/jcn.2010.6.1.33     Document Type: Article

References (30)

1. Grossman SA, Krabak MJ. Leptomeningeal carcinomatosis. Cancer Treat Rev 1999;25:103-119.
2. Kim SH, Jun DC, Park JS, Heo JH, Kim SM, Kim JH, et al. Primary diffuse leptomeningeal gliomatosis: report of a case presenting with chronic meningitis. J Clin Neurol 2006;2:202-205.
3. Seidenfeld J, Marton LJ. Biochemical markers of central nervous system tumors measured in cerebrospinal fluid and their potential use in diagnosis and patient management: a review. J Natl Cancer Inst 1979;63:919-931.
4. Ongerboer de Visser BW, Somers R, Nooyen WH, van Heerde P, Hart AA, McVie JG. Intraventricular methotrexate therapy of leptomeningeal metastasis from breast carcinoma. Neurology 1983;33:1565-1572.
5. van Zanten AP, Twijnstra A, Ongerboer de Visser BW, van Heerde P, Hart AA, Nooyen WJ. Cerebrospinal fluid tumour markers in patients treated for meningeal malignancy. J Neurol Neurosurg Psychiatry 1991;54:119-123.
6. Dhar P, Moore T, Zamcheck N, Kupchik HZ. Carcinoembryonic antigen (CEA) in colonic cancer. Use in preoperative and postoperative diagnosis and prognosis. JAMA 1972;221:31-35.
7. Holyoke ED. Present and probable uses of CEA. CA-Cancer J Clin 1975;25:22-26.
8. Reynoso G, Chu TM, Holyoke D, Cohen E, Nemoto T, Wang JJ, et al. Carcinoembryonic antigen in patients with different cancers. JAMA 1972;220:361-365.
9. Persijn JP, Korsten CB, Batterman JJ, Tierie AH, Renaud J. Clinical significance of urinary carcino-embryonic antigen estimations during the follow-up of patients with bladder carcinoma or previous bladder carcinoma. Clinical evaluation of carcino-embryonic antigen, III. J Clin Chem Clin Biochem 1976;14:395-399.
10. Kalser MH, Barkin JS, Redlhammer D, Heal A. Circulating carcinoembryonic antigen in pancreatic carcinoma. Cancer 1978;42(3 Suppl):1468-1471.
11. Loewenstein MS, Rittgers RA, Feinerman AE, Kupchik HZ, Marcel BR, Koff RS, et al. Carcinoembryonic antigen assay of ascites and detection of malignancy. Ann Intern Med 1978;88:635-638.
12. Schold SC, Wasserstrom WR, Fleisher M, Schwartz MK, Posner JB. Cerebrospinal fluid biochemical markers of central nervous system metastases. Ann Neurol 1980;8:597-604.
13. Wasserstrom WR, Schwartz MK, Fleisher M, Posner JB. Cerebrospinal fluid biochemical markers in central nervous system tumors: a review. Ann Clin Lab Sci 1981;11:239-251.
14. Snitzer LS, McKinney EC, Tejada F, Sigel MM, Rosomoff HL, Zubrod CG. Letter: Cerebral metastases and carcinoembryonic antigen in CSF. N Engl J Med 1975;293:1101.
15. Kido DK, Dyce BJ, Haverback BJ, Rumbaugh CL. Carcinoembryonic antigen in patients with untreated central nervous system tumors. Bull Los Angeles Neurol Soc 1976;41:47-54.
16. Norton JA. Carcinoembryonic antigen. New applications for an old marker. Ann Surg 1991;213:95-97.
17. Fletcher RH. Carcinoembryonic antigen. Ann Intern Med 1986;104: 66-73.
18. Egan ML, Lautenschleger JT, Coligan JE, Todd CW. Radioimmune assay of carcinoembryonic antigen. Immunochemistry 1972;9:289-299.
19. Dearnaley DP, Patel S, Powles TJ, Coombes RC. Carcinoembryonic antigen estimation in cerebrospinal fluid in patients with metastatic breast cancer. Oncodev Biol Med 1981;2:305-311.
20. Twijnstra A, Nooyen WJ, van Zanten AP, Hart AA, Ongerboer de Visser BW. Cerebrospinal fluid carcinoembryonic antigen in patients with metastatic and nonmetastatic neurological diseases. Arch Neurol 1986;43:269-272.
21. DeAngelis LM, Boutros D. Leptomeningeal metastasis. Cancer Invest 2005;23:145-154.
22. Jacobi C, Reiber H, Felgenhauer K. The clinical relevance of locally produced carcinoembryonic antigen in cerebrospinal fluid. J Neurol 1986;233:358-361.
23. Herbeth B, Bagrel A. A study of factors influencing plasma CEA levels in an unselected population. Oncodev Biol Med 1980;1:191-198.
24. Alexander JC, Silverman NA, Chretien PB. Effect of age and cigarette smoking on carcinoembryonic antigen levels. JAMA 1976;235: 1975-1979.
25. Kaplan JG, DeSouza TG, Farkash A, Shafran B, Pack D, Rehman F, et al. Leptomeningeal metastases: comparison of clinical features and laboratory data of solid tumors, lymphomas and leukemias. J Neurooncol 1990;9:225-229.
26. Little JR, Dale AJ, Okazaki H. Meningeal carcinomatosis. Clinical manifestations. Arch Neurol 1974;30:138-143.
27. Theodore WH, Gendelman S. Meningeal carcinomatosis. Arch Neurol 1981;38:696-699.
28. Ehya H, Hajdu SI, Melamed MR. Cytopathology of nonlymphoreticular neoplasms metastatic to the central nervous system. Acta Cytol 1981;25:599-610.
29. Klee GG, Tallman RD, Goellner JR, Yanagihara T. Elevation of carcinoembryonic antigen in cerebrospinal fluid among patients with meningeal carcinomatosis. Mayo Clin Proc 1986;61:9-13.
30. Freilich RJ, Seidman AD, DeAngelis LM. Central nervous system progression of metastatic breast cancer in patients treated with paclitaxel. Cancer 1995;76:232-236.